Press Release

United States Diagnostics Market to Grow with a CAGR of 9.12% through 2028

Increasing demand for point-of-care testing POCT and increasing adoption of automated platforms is expected to drive the United States Diagnostics Market growth in the forecast period, 2024-2028. 


According to TechSci Research report, “United States Diagnostics Market –Industry Size, Share, Trends, Competition Forecast & Opportunities, 2018-2028F”, the United States Diagnostics Market stood at USD 35.66 Billion in 2022 and is anticipated to project steady growth in the forecast period with a CAGR of 9.12% through 2028. The United States diagnostics market is experiencing a surge driven by several key factors. The prevalence of chronic diseases such as diabetes, cancer, and cardiovascular ailments is on the rise, necessitating an increased demand for diagnostic procedures.

Advancements in diagnostic technologies have revolutionized patient screening, disease diagnosis, and monitoring, thus propelling market growth. Government initiatives and investments in healthcare infrastructure, coupled with heightened health awareness among the population, are contributing to the expansion of the diagnostics market.


Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "United States Diagnostics Market


The United States Diagnostics Market refers to the thriving industry engaged in the development, production, and sale of cutting-edge medical diagnostic products and services across the nation. This expansive market encompasses a wide range of innovative and high-quality offerings, including state-of-the-art diagnostic imaging devices, advanced in-vitro diagnostic products, groundbreaking molecular diagnostics, and convenient point-of-care tests. With a relentless pursuit of progress, this dynamic market is constantly pushing the boundaries of innovation and technological advancements to provide healthcare professionals with efficient, accurate, and timely disease diagnosis tools.

In this ever-evolving landscape, the United States Diagnostics Market recognizes the importance of continuous improvement. By investing in research and development, the market strives to enhance the precision, sensitivity, and specificity of diagnostic tests. This commitment to innovation not only drives advancements in disease detection but also contributes to improved treatment outcomes and reduced healthcare costs. Furthermore, the United States Diagnostics Market plays a critical role in early and precise disease detection, significantly impacting patient care. By leveraging cutting-edge technologies and sophisticated analytical methods, healthcare professionals can diagnose diseases at their earliest stages, enabling timely intervention and personalized treatment plans. Through the integration of advanced artificial intelligence and machine learning algorithms, diagnostic tools are becoming smarter and more efficient, leading to faster and more accurate diagnoses.

Beyond the realm of patient care, the United States Diagnostics Market also contributes to the overall efficiency of the healthcare ecosystem. By streamlining diagnostic processes, reducing turnaround times, and optimizing resource utilization, healthcare providers can deliver quality care in a cost-effective manner. This not only benefits individual patients but also has broader societal implications by improving healthcare accessibility and affordability.

The United States Diagnostics Market is a vital component of the U.S. healthcare system. With its unwavering commitment to continuous innovation, this market strives to improve patient care, enhance treatment outcomes, and optimize the overall efficiency of the healthcare ecosystem. Through cutting-edge technologies, sophisticated analytical methods, and a collaborative approach, the United States Diagnostics Market is revolutionizing disease diagnosis and shaping the future of healthcare.

The United States Diagnostics Market is segmented into product type, type of test, technique, usability, application, end user, regional distribution, and company.

Based on end user, the United States Diagnostics Market is anticipated to be dominated by Hospitals. This is primarily due to the extensive network of hospitals spread across the nation, ensuring accessibility to diagnostic services for a large population. With their state-of-the-art infrastructure and skilled healthcare professionals, hospitals are able to provide comprehensive diagnostic services, covering a wide range of medical conditions. Moreover, hospitals play a crucial role in the United States Diagnostics Market by offering a holistic approach to patient care. In addition to diagnostic services, hospitals provide a range of other healthcare services, including inpatient and outpatient care, emergency services, and specialized treatments. This integrated approach allows for seamless coordination among different departments, ensuring a comprehensive and efficient patient experience.

Furthermore, hospitals are at the forefront of continuous advancements in diagnostic technologies. They invest heavily in research and development to improve imaging modalities and molecular diagnostics, enabling more accurate and timely diagnoses. These advancements contribute to hospitals' dominant position in the market, as they are able to offer cutting-edge diagnostic services that meet the evolving needs of patients and healthcare providers. The presence of hospitals as key players in the United States Diagnostics Market is driven by their extensive network, ability to offer a holistic approach to patient care, and continuous advancements in diagnostic technologies. This allows hospitals to consistently deliver high-quality diagnostic services and play a vital role in improving healthcare outcomes for the population.

Based on region, the Northeast region of the United States is poised to maintain its dominance in the US Diagnostics Market, owing to a multitude of strategic advantages. This region not only boasts numerous world-class research institutes and universities, but it also nurtures an environment that fosters innovation and the development of advanced diagnostics. Furthermore, the presence of leading diagnostic and biotech companies further strengthens its position in the sector. The region's dense population serves as a vast patient pool, ensuring ample opportunities for market growth. Moreover, the robust healthcare infrastructure, combined with the region's high healthcare expenditure, facilitates the rapid adoption of new diagnostic techniques, solidifying its continued dominance in the US Diagnostics Market. With its rich ecosystem of research, innovation, and patient base, the Northeast region remains at the forefront of advancing healthcare diagnostics in the United States.


Major companies operating in the United States Diagnostics Market are:

  • Abbott Laboratories, Inc.
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc.
  • Johnson & Johnson
  • Ortho-Clinical Diagnostics, Inc.
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories, Inc.
  • Roche Diagnostics Corporation
  • Siemens Medical Solutions USA, Inc.
  • Biomerieux Inc.


Download Free Sample Report      

Customers can also request 10% free customization on this report.


“The future of the United States diagnostics market is exceptionally promising, with projections indicating significant growth in the coming years. This growth will be driven by several factors, including advancements in technology, an aging population, and an increased focus on preventive healthcare. Additionally, liquid biopsies have emerged as a promising non-invasive method for detecting and monitoring diseases, such as cancer, by analyzing biomarkers present in bodily fluids. The United States diagnostics market is poised for significant growth, driven by technological advancements, evolving healthcare needs, and the recognition of the crucial role of diagnostics in improving patient outcomes. The integration of innovative technologies and a focus on personalized medicine are set to shape the future of diagnostics, enabling more precise and tailored medical interventions for better patient care.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

United States Diagnostics Market By Product Type (Reagents, Instruments, Software & Services), By Type of Test (Infectious Disease Testing, Lipid Panel, Metabolic Panel, Others), By Technique (Immunodiagnostics, Clinical Techniques, Molecular Diagnostics, Tissue Diagnostics, Others), By Usability (Reusable, Disposable), By Application (Infectious Diseases {Human Papillomavirus, Hepatitis, Tuberculosis, Hospital-Acquired Infections, COVID-19}, Cancer, Sexually Transmitted Diseases, Others), By End User (Hospitals, Public labs, Diagnostic Centers, Point-of-Care Testing Centers, Private or Commercial Laboratories, Others), By Region, Competition, Forecast and& Opportunities, 2018-2028F”, has evaluated the future growth potential of United States Diagnostics Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision-makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in United States Diagnostics Market.



Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York 10017

Tel: +1-646-360-1656

Email: [email protected]


Relevant News